Infection Control Market Size & Growth Forecast 2026–2035, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Infection Control Market size was over USD 255.86 Billion in 2025 and is likely to grow at a 6.8% CAGR between 2026 and 2035, crossing USD 493.99 Billion by 2035. The industry revenue for 2026 is estimated at USD 271.06 billion.

• Base Year Value (2025): USD 255.86 Billion
• CAGR (2026-2035): 6.8%
• Forecast Year Value (2035): USD 493.99 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Infection Control Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads with a 51.20% share, supported by strong hospital infrastructure, strict infection prevention protocols, and continuous demand for sterilization and disinfection across healthcare settings.
  • Asia Pacific is expanding at a 7.68% CAGR, driven by healthcare infrastructure expansion and increasing adoption of standardized hygiene and contamination-control practices in hospitals and labs.

• Segment Momentum:

  • Consumables lead the market because infection prevention protocols require continuous replenishment of products used in sterilization, disinfection, and contamination control, creating steady recurring demand.
  • Medical Device Companies are the fastest-growing end-use segment as infection control becomes increasingly important for contamination prevention, quality assurance, and regulatory compliance throughout production workflows.

• Market Expansion Drivers:

  • Increasing incidence of hospital-acquired infections driving demand for advanced sterilization solutions.
  • Government infection prevention guidelines accelerating healthcare investment in disinfection technologies.
  • Rising adoption of UV disinfection and antimicrobial surface technologies improving infection management outcomes.

• Industry Adoption Constraints:

• Leading Market Participants:

  Top companies in the infection control market include STERIS plc (United States), 3M Company (United States), Getinge AB (Sweden), Advanced Sterilization Products (United States), Belimed AG (Switzerland), Ecolab Inc. (United States), MMM Group (Germany), Sterigenics U.S. LLC (United States), Midmark Corporation (United States), W&H Dentalwerk Bürmoos GmbH (Austria).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 255.86 Billion
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 493.99 Billion by 2035
  • Growth Forecasts: 6.8% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Consumables (Type) | Hospitals (End-use)
  • Emerging Opportunity Segment: Services (Type) | Medical Device Companies (End-use)

Market Growth Drivers and Industry Trends

Increasing incidence of hospital-acquired infections driving demand for advanced sterilization solutions

Higher rates of hospital-acquired infections are pushing healthcare providers to reassess whether conventional cleaning and sterilization protocols are sufficient for increasingly complex care environments. In the infection control market, this pressure translates into stronger procurement of low-temperature sterilizers, automated endoscope reprocessors, biological monitoring systems, and validated sterilization workflows that reduce contamination risk around reusable instruments and high-touch clinical areas. Purchasing decisions are being shaped less by routine replacement cycles and more by the operational and financial burden of infection events, which is driving demand for systems that offer greater consistency, traceability, and compatibility with modern medical devices.

Government infection prevention guidelines accelerating healthcare investment in disinfection technologies

Stricter infection prevention guidance from health authorities and regulatory bodies is influencing how hospitals, clinics, and ambulatory care centers allocate capital toward compliant disinfection infrastructure. For the infection control market, guidelines function as a practical investment trigger because facilities must demonstrate standardized cleaning practices, validated disinfection performance, and stronger documentation during audits and accreditation reviews. That dynamic is strengthening market development for automated room disinfection systems, surface disinfection products, monitoring tools, and staff-support technologies that help institutions formalize protocols and reduce variability in day-to-day infection prevention practices.

Rising adoption of UV disinfection and antimicrobial surface technologies improving infection management outcomes

As providers look for ways to reduce pathogen persistence beyond manual cleaning alone, UV disinfection systems and antimicrobial surfaces are gaining traction as complementary layers of protection in high-risk healthcare settings. In the infection control market, adoption is being supported by the practical appeal of technologies that can improve consistency in terminal room disinfection, extend protection across frequently touched surfaces, and help facilities address contamination risks in areas where human-dependent cleaning may be uneven. This is influencing market penetration by shifting demand toward integrated infection prevention strategies that combine chemical disinfection with environmental technologies designed to improve infection management outcomes without heavily increasing labor intensity.

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 51.20% share of the infection control market in 2025, reflecting the region’s entrenched hospital infrastructure, high procedural volumes, and rigorous compliance requirements around sterilization, disinfection, and healthcare-associated infection prevention. Demand is sustained in practice by continual use of infection prevention consumables across acute care settings, laboratories, and surgical centers, while replacement cycles for sterilization and decontamination equipment remain active because providers operate under strict clinical protocols and accreditation standards.

Asia Pacific is projected to expand at a 7.68% CAGR over the forecast period, with the infection control market gaining momentum as healthcare capacity broadens and infection prevention standards become more embedded across hospitals and diagnostic settings. Growth is being accelerated by rising investment in healthcare infrastructure and the practical need to improve hygiene workflows, expand sterilization coverage, and support higher patient throughput, especially as providers modernize facilities and adopt more standardized contamination-control processes.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Restrictive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Strong	Strong	Moderate	Moderate
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	High	Medium	Low
New Entrants / Startups	Dense	Moderate	Dense	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

No card data available for this language/report.

Segment Leadership and Growth Trends

  Type Segment Analysis: Consumables (Largest Segment) vs Services (Fastest-Growing Segment)

Within the infection control market, Consumables held the largest share in 2025, reflecting their routine and unavoidable use across sterilization, disinfection, and contamination prevention workflows. Demand remains anchored in the recurring nature of infection control protocols, where items must be replenished continuously to support day-to-day hygiene compliance and patient safety standards. This steady replacement cycle gives Consumables a durable leadership position in the infection control market, especially because they are embedded directly into operational practice rather than tied to occasional capital purchasing decisions.

Services are emerging as the fastest-growing segment in the infection control market as healthcare and related facilities place greater emphasis on outsourced expertise, validation, and ongoing compliance support. Growth is being reinforced by the practical need to maintain consistent infection prevention performance across increasingly complex environments, where internal teams may not always have the capacity or specialized knowledge required. Compared with product-only approaches, services are gaining momentum because they help users manage implementation, monitoring, and regulatory adherence in a more continuous and structured way.

End-use Segment Analysis: Hospitals (Largest Segment) vs Medical Device Companies (Fastest-Growing Segment)

Hospitals accounted for the largest share of the infection control market in 2025, supported by the constant need to manage infection risks across high-volume patient care settings. Their leadership is maintained through the breadth of infection control requirements spanning surgical areas, intensive care units, inpatient rooms, and general clinical operations, all of which require continuous use of products and procedures designed to reduce contamination. In the infection control market, hospitals remain the leading end-use segment because infection prevention is directly tied to everyday care delivery, operational continuity, and patient outcomes.

Medical Device Companies represent the fastest-growing end-use segment in the infection control market, driven by the rising need to ensure product safety and maintain tightly controlled manufacturing and handling environments. Growth is being supported by the practical requirement to prevent contamination throughout device production and processing, where infection control measures are critical to quality assurance and regulatory compliance. Relative to more established end users, this segment is gaining pace as infection control becomes more deeply integrated into device development, production workflows, and market approval expectations.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Equipment, Services, Consumables	Consumables	Services
End-use	Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Laboratories, Others	Hospitals	Medical Device Companies

Competitive Landscape and Market Positioning

Leading companies in the infection control market:

1. STERIS plc (United States)

2. 3M Company (United States)

3. Getinge AB (Sweden)

4. Advanced Sterilization Products (United States)

5. Belimed AG (Switzerland)

6. Ecolab Inc. (United States)

7. MMM Group (Germany)

8. Sterigenics U.S. LLC (United States)

9. Midmark Corporation (United States)

10. W&H Dentalwerk Bürmoos GmbH (Austria)

The infection control market is undergoing rapid development as healthcare providers seek advanced sterilization technologies and environmentally sustainable disinfection solutions. Companies are introducing integrated infection prevention systems that improve operational efficiency while meeting evolving healthcare safety regulations. Within the infection control market, rising investment in automated cleaning technologies and antimicrobial innovations is strengthening competitive differentiation.

Industry Development/News

Company Name	Date	Key Development
Getinge	Mar-23	Getinge acquired Ultra Clean Systems Inc. to integrate specialized ultrasonic cleaning technologies into its surgical instrument processing portfolio. The transaction directly enhances Getinge's capability to address sterilization demands for complex and robotic surgery tools, strengthening its competitive positioning in high-precision hospital infection control markets.
Midmark Corporation	Jul-24	Midmark Corporation commercialized its next-generation M11 and M9 steam sterilizers, introducing integrated compliance documentation capabilities and optimized instrument processing efficiencies. This product launch directly addresses hospital demands for standardized, data-verifiable infection control workflows and enhanced hardware durability.
W&H Dentalwerk	Jan-23	W&H Dentalwerk launched the Lexa Plus sterilizer, a pre-vacuum Class B sterilizer custom-engineered for the North American dental and medical markets. The strategic introduction expands the company's regional footprint in medical device reprocessing and satisfies regional healthcare facility compliance requirements.
Seegene	May-26	Seegene commercialized a novel PCR-based molecular diagnostic assay in Europe specifically designed to identify multidrug-resistant organisms. This technology integration advances early detection workflows for resistant pathogens, allowing acute care hospitals to mitigate horizontal transmission risks and strengthen targeted containment protocols.
Novant Health Thomasville Medical Center	Jul-24	Novant Health deployed the SwipeSense digital monitoring platform to automate hand hygiene compliance tracking, raising facility adherence rates from 53% to 84%. The initiative demonstrates the growing commercial scalability and operational impact of IoT-driven behavioral tracking systems in reducing healthcare-associated infections.
Apollomedics Hospitals	May-26	Apollomedics Hospitals integrated the MISSO robotic system to execute 500 robotic knee surgeries, utilizing minimally invasive parameters to optimize perioperative infection control. The adoption highlights a broader operational shift toward robotic platforms that inherently lower surgical site contamination risks compared to traditional open procedures.